1. Home
  2. VRME vs SNSE Comparison

VRME vs SNSE Comparison

Compare VRME & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VerifyMe Inc.

VRME

VerifyMe Inc.

HOLD

Current Price

$0.63

Market Cap

10.4M

Sector

Technology

ML Signal

HOLD

Logo Sensei Biotherapeutics Inc.

SNSE

Sensei Biotherapeutics Inc.

HOLD

Current Price

$8.88

Market Cap

10.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRME
SNSE
Founded
1999
2005
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.4M
10.3M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
VRME
SNSE
Price
$0.63
$8.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$1.50
$72.50
AVG Volume (30 Days)
443.8K
81.6K
Earning Date
11-14-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$21,669,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$16.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$5.00
52 Week High
$5.00
$18.35

Technical Indicators

Market Signals
Indicator
VRME
SNSE
Relative Strength Index (RSI) 38.67 50.35
Support Level $0.65 $8.50
Resistance Level $0.67 $9.60
Average True Range (ATR) 0.04 0.69
MACD 0.00 0.09
Stochastic Oscillator 4.40 70.44

Price Performance

Historical Comparison
VRME
SNSE

About VRME VerifyMe Inc.

VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.

About SNSE Sensei Biotherapeutics Inc.

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).

Share on Social Networks: